Condition

T-Cell Acute Lymphoblastic Lymphoma clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• CD7 CAR T therapy for high-risk T-cell cancers

  This study tests a patient’s own edited T cells, engineered to target CD7, in people with relapsed or high-risk T-cell leukemia or lymphoma.

  Recruiting Phase 1 Baylor College of Medicine · Houston, Texas and 1 other locations · NCT07220993

• Targeted immunotherapy for high-risk T-cell leukemia and lymphoma in young patients

  This study is testing a new treatment called daratumumab for young patients with high-risk T-cell leukemia and lymphoma to see if it is safe and helps improve their outcomes after a stem cell transplant.

  Recruiting at 8 sites Phase 1 New York Medical College · Phoeniz, Arizona and 15 other locations · NCT04972942

Related topics

Quick answers

How many T-Cell Acute Lymphoblastic Lymphoma clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in United States. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →